基本信息
浏览量:2
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Chandra Vargeese, Ph.D. is currently the Chief Technology Officer at Wave Life Sciences. During the period of August 2014 to April 2020, Dr. Vargeese served as Senior Vice President, Head of Drug Discovery. Before joining Wave, Dr. Vargeese served as Novartis’ Executive Director and Head of RNA Chemistry and Delivery, a position she held from 2008 to 2014. Prior to joining Novartis, Dr. Vargeese led siRNA delivery in the RNA Therapeutics division at Merck & Co., where she served as Senior Director and Head of RNA Chemistry and Delivery. Dr. Vargeese joined Merck through its acquisition of Sirna Therapeutics, where she was Vice President of Chemistry. Before Sirna, Dr. Vargeese served as Associate Director of Chemistry at NeXstar Pharmaceuticals and is the co-inventor of Macugen (pegaptanib), an approved therapy for treating wet AMD. Dr. Vargeese earned a Ph.D. in Organic Chemistry at the Indian Institute of Science, Bangalore, India and completed post-doctoral work at the University of Rhode Island.
研究兴趣
论文共 50 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Prashant Monian,Chikdu Shivalila,Genliang Lu,Keith Bowman, Marissa Bylsma,Michael Byrne,Megan Cannon,Jigar Desai, Alyse Faraone,Frank Favaloro,Anamitra Ghosh,Jack Godfrey,
MOLECULAR THERAPYno. 4 (2023): 45-45
引用0浏览0引用
0
0
Pachamuthu Kandasamy,Graham McClorey,Laurent Servais,Craig Campbell,Xiao Shelley Hu, Andrew Hart,Joseph A. Haegele,Kuldeep Singh, Jeanette Rheinhardt,Anamitra Ghosh,Mamoru Shimizu, Nayantara Kothari,
MOLECULAR THERAPYno. 4 (2023): 46-46
引用0浏览0引用
0
0
Chikdu Shivalila, Ian Harding,Prashant Monian,Genliang Lu,Keith Bowman,Michael Byrne,Arindom Chatterjee,Jigar Desai, Jason Dufresne,Frank Favaloro, Stephen Friend,Jack Godfrey,
MOLECULAR THERAPYno. 4 (2023): 580-581
引用0浏览0引用
0
0
MOLECULAR THERAPYno. 4 (2023): 780-780
引用0浏览0引用
0
0
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn